Research cutoff: September 13, 2026. Dollar amounts are USD per common share unless stated otherwise. This guide separates declared payments, calculations and unannounced future decisions.
AbbVie has declared four $1.73 payments with calendar-2026 payable dates, including a November 16 distribution announced September 10. They total $6.92 per share. That declared calendar total must still be separated from cash already paid and from any unannounced 2027 decisions.
ABBV’s 2026 dividend record is now more complete
The issuer’s dividend table lists the first three distributions. The September 10 declaration supplies the fourth. Using the newer announcement alongside the table avoids treating an older three-payment display as the complete current record.
On a small screen, swipe the table horizontally. Keyboard users can focus the table region and use the arrow keys.
| Record date | Payable date | Per share | Timing at September 13 |
|---|---|---|---|
| January 16 | February 17, 2026 | $1.73 | Past payable date |
| April 15 | May 15, 2026 | $1.73 | Past payable date |
| July 15 | August 14, 2026 | $1.73 | Past payable date |
| October 15 | November 16, 2026 | $1.73 | Declared future payment |
The first three sum to $5.19 per share. The November declaration adds $1.73, producing $6.92 across all four. For 100 shares eligible for each distribution, the amounts are $519 for the first three and $173 for the fourth. Those are gross company entitlements under the stated share assumption, not a verification of an individual brokerage account.
A 2027 dividend outlook without inventing a raise
On a small screen, swipe the table horizontally. Keyboard users can focus the table region and use the arrow keys.
| Payment assumptions | Annual per share | 100 eligible shares |
|---|---|---|
| Four × $1.73 | $6.92 | $692 |
| Four × hypothetical $1.80 | $7.20 | $720 |
| Two × $1.73 plus two × hypothetical $1.80 | $7.06 | $706 |
| Four × hypothetical $1.50 | $6.00 | $600 |
The $1.80 and $1.50 rates are illustrative inputs rather than company guidance. The higher-rate timing cases differ by $14 for 100 shares. None establishes a guaranteed minimum, an exact payment date or a probability of approval. A projected increase should remain outside a fixed spending commitment until the relevant declaration is confirmed.
What should support the dividend beyond the headline yield?
Our AbbVie review focuses on the cash produced by the commercial portfolio after research, manufacturing and other operating needs. Inspect the contribution of newer products alongside pressure on mature products rather than projecting consolidated sales growth into perpetuity. A treatment’s commercial prospects and its development costs can change at different speeds, making the timing of cash important.
Reported profit and adjusted profit can differ materially in a pharmaceutical company. Understand amortization, acquired research costs and other adjustments before selecting a payout-ratio denominator. An adjustment may explain accounting comparability without making a real cash commitment disappear. Also evaluate debt maturities, acquisitions and repurchases as competing uses of resources. Dividend coverage is a capital-allocation question, not a conclusion reached from one earnings metric.
AbbVie, Abbott and the meaning of a share distribution
AbbVie’s first full-year results after separation describe the January 1, 2013 distribution of AbbVie shares by Abbott. This created a separately traded company. It should not be described as a recurring annual bonus on today’s ABBV shares or confused with an ordinary forward split. No new 2026 or 2027 split ratio or distribution date is verified here.
In a forward split, the same company’s shares are divided into a different number of units. In a separation, shareholders can receive an interest in a distinct business. Cash dividends are a third category. Keeping those events separate prevents a historic spin-off from being promoted as evidence that current shareholders will automatically receive additional stock next year.
Interpreting dividend yield and reinvestment
At an illustrative $250 share price, the $6.92 unchanged-rate scenario corresponds to a 2.768% indicated yield. Neither the price nor the scenario is a valuation target. A higher yield caused by a falling price does not necessarily mean a distribution is more secure. Evaluate potential capital losses and company concentration alongside the expected cash.
Reinvestment can increase the number of shares held, but the price at which dividends buy stock remains unknown in advance. Do not combine a fixed-share income example with an assumption that every dividend is automatically reinvested; that requires a separate path-dependent calculation and account-specific settings.
Frequently asked questions
Are all four 2026 amounts declared?
Yes, the four reviewed declarations total $6.92 per share. November’s amount is still a future payment at the cutoff.
Does that confirm the same amount in 2027?
No. Continuing the rate for four future payments is a scenario requiring future approvals.
Continue your research
Read our share-distribution research for the wider business context, or compare our September dividend research. A dividend is one part of total return, not protection against a fall in the share price.
LiveTodayStock editorial research. Educational information, not personalized investment advice. Cash examples are gross, exclude taxes and fees, and assume the specified shares qualified for each distribution. Future dividends require board approval.